Morgan Stanley’s BNY Mellon Concentrated Growth ETF BKCG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$392K Sell
9,935
-1,682
-14% -$65.1K ﹤0.01% 5704
2026
Q2
$433K Sell
11,617
-467
-4% -$17.3K ﹤0.01% 5613
2026
Q1
$411K Sell
12,084
-278
-2% -$10K ﹤0.01% 5576
2025
Q4
$450K Sell
12,362
-243
-2% -$8.74K ﹤0.01% 5563
2025
Q3
$450K Buy
12,605
+2,800
+29% +$97.5K ﹤0.01% 5543
2025
Q2
$339K Buy
9,805
+164
+2% +$5.22K ﹤0.01% 5637
2025
Q1
$298K Buy
+9,641
New +$298K ﹤0.01% 5566

Other funds holding BKCG

Morgan Stanley's BKCG Position: Q3 2026 in Review

Morgan Stanley reduced its BNY Mellon Concentrated Growth ETF (BKCG) stake by 14% in Q3 2026, selling an estimated $65.1K and leaving 9,935 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #5704.

Morgan Stanley first reported a position in BKCG in Q1 2025 and has held it in 7 quarters since. The position peaked at $450K in Q4 2025. 24 funds tracked by Wall St. Rank hold BKCG as of Q3 2026.

  • Morgan Stanley held 9,935 shares of BNY Mellon Concentrated Growth ETF worth $392K as of Q3 2026.
  • Morgan Stanley sold 1,682 BNY Mellon Concentrated Growth ETF shares in Q3 2026, an estimated $65.1K.
  • BNY Mellon Concentrated Growth ETF made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #5704 holding.
  • Morgan Stanley first reported a position in BNY Mellon Concentrated Growth ETF in Q1 2025 and has held it in 7 quarters since.
  • Morgan Stanley's BNY Mellon Concentrated Growth ETF position peaked at $450K in Q4 2025.
  • 24 funds tracked by Wall St. Rank held BNY Mellon Concentrated Growth ETF as of Q3 2026.

Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.